New Coronavirus Proteins for Diagnostic and Therapeutic Development

33030 - DDN Industry Perspectives Logo - JR -WHITE
February 5, 2021 | 2:30 PM EST 

Register for the Webinar

Already registered?
Access the webinar here »

The SARS-CoV-2 Spike protein is often the main target of COVID-19 therapeutic research efforts. Yet, numerous other structural and non-structural proteins (NSPs) comprise the SARS-CoV-2 virus. A greater understanding of coronavirus-related antigens is critical for optimizing the research, development, and manufacturing of novel therapeutics and robust diagnostics. In this webinar sponsored by R&D Systems, part of the Bio-Techne Corporation, Anthony Person will discuss novel protein-based assays for COVID-19 and how they can advance diagnostic and therapeutic development.

Topics to be covered

  • Newly discovered genetic Spike variants, Spike glycosylation, ACE-2, proteases, and non NSPs
  • How new protein-based tools can help advance the development of clinical applications 

Speaker Information:


Anthony Person, PhD

Sr. Director, Protein Business Unit


Interested in sponsoring a webinar?
Click here to contact our friendly sales team.

Webinar Sponsors

R&D -Webinar June 2 logo -BT_BT-main-logo-spot-color-blue